Paul A. Wender Ph.D.
|Age||Total Calculated Compensation||This person is connected to 34 board members in 2 different organizations across 3 different industries.|
See Board Relationships
Prof. Paul A. Wender, Ph.D. co-founded Progen Pharmaceuticals, Inc. in 1998 and served as its Chief Scientific Advisor. Prof. Wender serves as a Consultant to various pharmaceutical companies. Prof. Wender is a Co-Founder of Quantitative Chemical Biology Program at Stanford University. He has joint appointment in Chemistry and in the Medical School at Stanford University. He was Bergstrom Professor of Chemistry and Professor of Molecular Pharmacology at Stanford University. ...
2479 East Bayshore RoadPhone: 650-610-7800
Palo Alto, California 94303
Board Members Memberships*There is no Board Members Memberships data available.
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
|There is no Competitor Compensation data available.|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.